Cargando…

Avelumab plus axitinib therapy for renal cell carcinoma in a patient with pulmonary alveolar proteinosis: A case report

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the abnormal accumulation of surfactant-derived substances in the lungs. To the best of our knowledge, the successful treatment of metastatic renal cell carcinoma in patients with PAP has not been reported. Here, we describe suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Nobuaki, Hasumi, Masaru, Muramatsu, Kazumichi, Tsuji, Yusuke, Takaku, Youtarou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436122/ https://www.ncbi.nlm.nih.gov/pubmed/34540590 http://dx.doi.org/10.1016/j.eucr.2021.101843

Ejemplares similares

Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava
por: Uematsu, Toshitaka, et al.
Publicado: (2022)

Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report
por: Uekawa, Ayano, et al.
Publicado: (2022)

Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma
por: Zhang, Yue, et al.
Publicado: (2019)

A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma
por: Tiako Meyo, Manuela, et al.
Publicado: (2022)

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
por: Uemura, Motohide, et al.
Publicado: (2020)

A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma
por: Lu, Peiyao, et al.
Publicado: (2020)

Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
por: Tanaka, Yuko, et al.
Publicado: (2019)

Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013)

Pulmonary alveolar proteinosis in children
por: Bush, Andrew, et al.
Publicado: (2020)

Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101
por: Tomita, Y., et al.
Publicado: (2022)

Pulmonary alveolar proteinosis in a cat
por: Szatmári, Viktor, et al.
Publicado: (2015)

Pulmonary Alveolar Proteinosis with Ulcerative Colitis
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Pulmonary alveolar proteinosis with peripheral adenocarcinom
por: Zhang, Ning, et al.
Publicado: (2018)

Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022)

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
por: Choueiri, T. K., et al.
Publicado: (2020)

Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial
por: Larkin, James, et al.
Publicado: (2022)

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial
por: Choueiri, T.K., et al.
Publicado: (2021)

Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101
por: Tomita, Y., et al.
Publicado: (2022)

A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib
por: Suzuki, Issei, et al.
Publicado: (2021)

Whole lung lavage for pulmonary alveolar proteinosis
por: Jayaraman, S., et al.
Publicado: (2010)

Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
por: Campo, Ilaria, et al.
Publicado: (2012)

Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
por: Tokman, Sofya, et al.
Publicado: (2016)

Prevalence and healthcare burden of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)

Pulmonary alveolar proteinosis: from classification to therapy
por: Salvaterra, Elena, et al.
Publicado: (2020)

Valuable Serum Markers in Pulmonary Alveolar Proteinosis
por: Shi, Shenyun, et al.
Publicado: (2019)

Pulmonary alveolar proteinosis after lung transplantation
por: Divithotawela, Chandima, et al.
Publicado: (2020)

Pulmonary alveolar proteinosis with an unusual bronchoscopic complication
por: Sweeney, Duncan J., et al.
Publicado: (2021)

Sirolimus-induced secondary pulmonary alveolar proteinosis
por: Wang, Stephanie, et al.
Publicado: (2021)

Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
por: Sakaue, Saori, et al.
Publicado: (2021)

Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
por: Hinojosa-González, David Eugenio, et al.
Publicado: (2020)

Atypical alveolar proteinosis
por: Rajaonarison Ny Ony Narindra, Lova Hasina, et al.
Publicado: (2018)

Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies
por: Huang, Xinmei, et al.
Publicado: (2023)

Pulmonary alveolar proteinosis and superinfection with pulmonary tuberculosis in a case
por: Tekgül, Serpil, et al.
Publicado: (2011)

Pulmonary alveolar proteinosis in children: a case series
por: Tabatabaei, Seyyed Ahmad, et al.
Publicado: (2010)

Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis
por: Tian, Xinlun, et al.
Publicado: (2011)

Pulmonary alveolar proteinosis treatment by whole-lung lavage
por: Cai, Chang, et al.
Publicado: (2012)

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)

Novel application of cryobiopsy in the diagnosis of pulmonary alveolar proteinosis
por: Shen, Meng‐fang, et al.
Publicado: (2018)

Pulmonary alveolar proteinosis - a crazy presentation of dyspnea
por: Skov, Inge Raadal, et al.
Publicado: (2018)

Autoimmune pulmonary alveolar proteinosis prior to myelodysplastic syndrome
por: Foo, Chuan Tai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ra6tg2k8917f7lncctreqqp3be